DGAP-News

aap: Significant sales increases in Q2 (+74%) and H1 (+37%) underline growth targets for FY/2021; USA for first time with EUR 1 million sales quarter

DGAP-News: aap Implantate AG / Key word(s): Half Year Results/Preliminary Results aap: Significant sales increases in Q2 (+74%) and H1 (+37%) underline growth targets for FY/2021; USA for first time with EUR 1 million sales quarter 27.07.2021 / 10:17 The issuer is solely responsible for the content of this announcement. aap Implantate AG ("aap" or the "Company") recorded significant sales growth in both the second quarter and the first half of 2021. According to preliminary figures, aap increased sales in the second quarter of 2021 by a noticeable 74% year-on-year to EUR 3.3 million (Q2/2020: EUR 1.9 million). In the first six months of the current financial year, sales also increased significantly by 37% year-on-year to EUR 6.0 million (H1/2020: EUR 4.4 million). Taking into account constant exchange rates, the growth rates were even 79% (Q2) and 41% (H1). Overall, aap thus continues to be on a growth track after the good start in the first quarter and underlines its ambitious growth targets for the financial year 2021 (+29 to +61% vs. FY/2020) with the significant sales increases in the second quarter.   Sales Q2/2021

in KEUR	Q2/2021	Q2/20201)	Change
Sales Germany USA USA Distributors USA Global Partners International (without USA) Europe (without Germany) BRICS Countries RoW (Rest of World)	3,264 578 1,006 992 14 1,680 494 339 847	1,875 559 584 559 25 732 248 230 254	+74% +3% +72% +77% -44% >+100% +99% +47% >+100%
Sales	3,264	1,875	+74%